Format

Send to

Choose Destination
Crit Care. 2018 Oct 28;22(1):274. doi: 10.1186/s13054-018-2202-y.

Angiotensin converting enzyme defects in shock: implications for future therapy.

Author information

1
Veterans Affairs Medical Center, San Diego, CA, USA. minkchawla@gmail.com.
2
La Jolla Pharmaceutical Company, 4550 Towne Centre Court, San Diego, CA, 92121, USA. minkchawla@gmail.com.
3
La Jolla Pharmaceutical Company, 4550 Towne Centre Court, San Diego, CA, 92121, USA.
4
School of Medicine, The University of Melbourne, Parkville, Melbourne, VIC, Australia.
5
Stanford School of Medicine, Stanford, CA, USA.

KEYWORDS:

ACE defect; Angiotensin insufficiency; Bradykinin; Sepsis; Vasodilatory; Vasodilatory shock

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center